IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Merial, Inc v Intervet International B.V. [2018] APO 52
Patent Application: 2011268899
Title:Injectable formulation of a macrocyclic lactone and levamisole
Patent Applicant: Intervet International B.V
Opponent: Merial, Inc
Delegate: K. Wagg
Decision Date: 17 August 2018
Hearing Date: 22 May 2018, in Canberra
Catchwords: PATENTS - – s59 – grounds of novelty, inventive step, fair basis and utility –all grounds unsuccessful – variation in costs due to amendment
Representation: Patent attorneys for the Applicant: David Myers & Matthew Stewart
Counsel for the Opponent: Christian Dimitriadis SC & Clare Cunliffe
Patent attorneys for the Opponent: Marcus Caulfield & Corrine Porter
IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Patent Application: 2011268899
Title:Injectable formulation of a macrocyclic lactone and levamisole
Patent Applicant: Intervet International B.V.
Date of Decision: 17 August 2018
DECISION
The Opposition is unsuccessful. Subject to appeal, I direct the application proceed to grant.
Costs according to Schedule 8 are awarded against the applicant until the date of advertisement of allowance of the amendment to the specification (9 October 2017) and against the opponent thereafter.
REASONS FOR DECISION
Background
Patent application 2011268899 (the application) is the Australian national phase entry of PCT/EP2011/060535, which was filed on 23 June 2011 and claims a priority date of 24 June 2010. Examination was requested on 11 April 2013. Consequently, substantive amendments of the Patents Act 1990 brought about by the Intellectual Property Laws Amendment (Raising the Bar) Act 2012 (Raising the Bar) do not apply to the present application. This includes the amendment to subsection 60 (3A) that allows the Commissioner to refuse a patent application if satisfied on the balance of probabilities that a ground of opposition exists. Any subsequent references to sections of the Patents Act relate to the Patents Act 1990 prior to amendment by the Raising the Bar Act. A similar qualification applies to references to the Patents Regulations 1991.
The applicant is Intervet International B.V. (the Applicant). The application was examined and advertised as accepted by the Commissioner on 7 July 2016. Merial Inc. (the Opponent) filed a notice of opposition to grant on 7 October 2016. After evidence in support was filed, the Applicant sought leave to amend the specification, including the claims, on 19 June 2017. Those amendments were allowed on 9 October 2017. The Statement of Grounds and Particulars was substantively amended in response on 27 September 2017 (Amended SGP)
A hearing was held on 22 May 2018 in Canberra to decide the opposition. The Opponent was represented by Christian Dimitriadis of counsel, accompanied by Clare Cunliffe, with Marcus Caulfield and Corrine Porter of FB Rice. The Applicant was represented by David Myers of Spruson & Ferguson, accompanied by Matthew Stewart.
The Amended SGP identified 8 grounds of opposition. At the hearing the following grounds were pressed:
oLack of Novelty
oLack of Inventive Step
oInutility
oLack of Fair Basis
Standard of Proof
The onus of proof in this opposition proceeding rests with the Opponent, who must establish that it is clear or…
Keep reading for free
Create a free CaseChat account to read Merial, Inc v Intervet International B.V and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2018] APO 52
- Decision Date
CaseChat Overview and Summary
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.